GSDMD and neoplasm: When endometrial or ovarian cancer cells are exposed to the reversible acetylcholine transferase inhibitor α-NETA, there is an induction of pyroptosis through the GSDMD/caspase-4 mechanism, leading to suppressed tumor growth in mouse models (64, 90).